ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00134953
Recruitment Status : Terminated (The Principal Investigator left the clinic and there was no one who could take over this study.)
First Posted : August 25, 2005
Last Update Posted : December 17, 2007
Sponsor:
Information provided by:
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2004